Envision Healthcare Co. (EVHC) Shares Sold by University of Notre Dame DU Lac

University of Notre Dame DU Lac reduced its stake in Envision Healthcare Co. (NYSE:EVHC) by 57.8% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 49,498 shares of the company’s stock after selling 67,752 shares during the period. University of Notre Dame DU Lac’s holdings in Envision Healthcare were worth $2,225,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Commonwealth Bank of Australia raised its holdings in Envision Healthcare by 24.3% in the 2nd quarter. Commonwealth Bank of Australia now owns 2,096 shares of the company’s stock valued at $130,000 after buying an additional 410 shares during the period. LMR Partners LLP purchased a new stake in Envision Healthcare in the 2nd quarter valued at about $205,000. Cutter & CO Brokerage Inc. increased its stake in Envision Healthcare by 11.1% during the second quarter. Cutter & CO Brokerage Inc. now owns 3,668 shares of the company’s stock worth $230,000 after purchasing an additional 367 shares during the period. Flinton Capital Management LLC increased its stake in Envision Healthcare by 18.7% during the second quarter. Flinton Capital Management LLC now owns 4,464 shares of the company’s stock worth $280,000 after purchasing an additional 704 shares during the period. Finally, D.A. Davidson & CO. increased its stake in Envision Healthcare by 30.0% during the second quarter. D.A. Davidson & CO. now owns 4,589 shares of the company’s stock worth $287,000 after purchasing an additional 1,059 shares during the period.

Envision Healthcare Co. (NYSE:EVHC) traded up $0.40 during mid-day trading on Wednesday, hitting $31.23. 2,627,000 shares of the company were exchanged, compared to its average volume of 2,237,490. The company has a debt-to-equity ratio of 0.89, a current ratio of 3.01 and a quick ratio of 3.00. Envision Healthcare Co. has a 12-month low of $23.77 and a 12-month high of $74.19. The stock has a market capitalization of $3,727.02, a price-to-earnings ratio of 9.52, a price-to-earnings-growth ratio of 0.80 and a beta of 0.57.

Envision Healthcare (NYSE:EVHC) last released its earnings results on Tuesday, October 31st. The company reported $0.73 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.81 by ($0.08). Envision Healthcare had a positive return on equity of 4.88% and a negative net margin of 6.39%. The firm had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $2.03 billion. During the same quarter in the previous year, the company posted $1.13 earnings per share. The firm’s quarterly revenue was up 142.0% on a year-over-year basis. sell-side analysts forecast that Envision Healthcare Co. will post 2.57 earnings per share for the current fiscal year.

Envision Healthcare announced that its board has authorized a share buyback program on Monday, September 18th that permits the company to buyback $250.00 million in outstanding shares. This buyback authorization permits the company to purchase up to 4.5% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board believes its shares are undervalued.

EVHC has been the topic of a number of recent research reports. Mizuho cut their price target on shares of Envision Healthcare from $65.00 to $57.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 9th. Zacks Investment Research upgraded shares of Envision Healthcare from a “sell” rating to a “hold” rating in a research note on Friday, August 11th. BidaskClub lowered shares of Envision Healthcare from a “sell” rating to a “strong sell” rating in a research note on Thursday, August 17th. Jefferies Group set a $71.00 price target on shares of Envision Healthcare and gave the stock a “buy” rating in a research note on Thursday, August 24th. Finally, Bank of America cut their price target on shares of Envision Healthcare from $72.00 to $60.00 and set a “buy” rating on the stock in a research note on Monday, October 9th. One analyst has rated the stock with a sell rating, six have issued a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $47.57.

ILLEGAL ACTIVITY WARNING: “Envision Healthcare Co. (EVHC) Shares Sold by University of Notre Dame DU Lac” was first posted by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece of content can be viewed at https://stocknewstimes.com/2017/12/06/envision-healthcare-co-evhc-shares-sold-by-university-of-notre-dame-du-lac.html.

About Envision Healthcare

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Institutional Ownership by Quarter for Envision Healthcare (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Co. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply